vs
Side-by-side financial comparison of ENANTA PHARMACEUTICALS INC (ENTA) and LCNB CORP (LCNB). Click either name above to swap in a different company.
LCNB CORP is the larger business by last-quarter revenue ($23.9M vs $18.6M, roughly 1.3× ENANTA PHARMACEUTICALS INC). LCNB CORP runs the higher net margin — 23.7% vs -64.1%, a 87.8% gap on every dollar of revenue. On growth, ENANTA PHARMACEUTICALS INC posted the faster year-over-year revenue change (9.8% vs 5.1%). LCNB CORP produced more free cash flow last quarter ($33.4M vs $-11.8M). Over the past eight quarters, LCNB CORP's revenue compounded faster (15.7% CAGR vs 4.5%).
Enanta Pharmaceuticals Inc is a clinical-stage biotechnology company that develops innovative antiviral therapies for infectious diseases including hepatitis B virus, respiratory syncytial virus (RSV), and SARS-CoV-2. It operates primarily in the U.S. and global markets, partnering with pharmaceutical firms to advance its small molecule drug candidate pipeline for patients with unmet medical needs.
LCNB Corp is a United States-based financial holding company that operates through its national bank subsidiary, providing a full suite of retail and commercial banking products and services including deposit accounts, various loan products, wealth management, and insurance solutions primarily to individual consumers, small and medium-sized enterprises and local community organizations across regional markets in Ohio.
ENTA vs LCNB — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $18.6M | $23.9M |
| Net Profit | $-11.9M | $5.7M |
| Gross Margin | — | — |
| Operating Margin | -60.5% | 29.2% |
| Net Margin | -64.1% | 23.7% |
| Revenue YoY | 9.8% | 5.1% |
| Net Profit YoY | 46.4% | -7.6% |
| EPS (diluted) | $-0.42 | $0.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $18.6M | $23.9M | ||
| Q3 25 | $15.1M | $23.8M | ||
| Q2 25 | $18.3M | $22.8M | ||
| Q1 25 | $14.9M | $21.5M | ||
| Q4 24 | $17.0M | $22.7M | ||
| Q3 24 | $14.6M | $21.4M | ||
| Q2 24 | $18.0M | $19.3M | ||
| Q1 24 | $17.1M | $17.8M |
| Q4 25 | $-11.9M | $5.7M | ||
| Q3 25 | $-18.7M | $6.9M | ||
| Q2 25 | $-18.3M | $5.9M | ||
| Q1 25 | $-22.6M | $4.6M | ||
| Q4 24 | $-22.3M | $6.1M | ||
| Q3 24 | $-28.8M | $4.5M | ||
| Q2 24 | $-22.7M | $925.0K | ||
| Q1 24 | $-31.2M | $1.9M |
| Q4 25 | -60.5% | 29.2% | ||
| Q3 25 | -121.6% | 35.6% | ||
| Q2 25 | -103.2% | 31.6% | ||
| Q1 25 | -164.3% | 25.6% | ||
| Q4 24 | -138.8% | 32.9% | ||
| Q3 24 | -204.4% | 24.9% | ||
| Q2 24 | -134.6% | 4.9% | ||
| Q1 24 | -192.1% | 12.5% |
| Q4 25 | -64.1% | 23.7% | ||
| Q3 25 | -123.6% | 29.1% | ||
| Q2 25 | -99.7% | 26.0% | ||
| Q1 25 | -151.7% | 21.4% | ||
| Q4 24 | -131.4% | 27.0% | ||
| Q3 24 | -197.3% | 21.2% | ||
| Q2 24 | -126.1% | 4.8% | ||
| Q1 24 | -182.7% | 10.7% |
| Q4 25 | $-0.42 | $0.40 | ||
| Q3 25 | $-0.88 | $0.49 | ||
| Q2 25 | $-0.85 | $0.41 | ||
| Q1 25 | $-1.06 | $0.33 | ||
| Q4 24 | $-1.05 | $0.44 | ||
| Q3 24 | $-1.36 | $0.31 | ||
| Q2 24 | $-1.07 | $0.07 | ||
| Q1 24 | $-1.47 | $0.15 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $37.4M | $21.6M |
| Total DebtLower is stronger | — | $104.4M |
| Stockholders' EquityBook value | $126.6M | $273.9M |
| Total Assets | $329.5M | $2.2B |
| Debt / EquityLower = less leverage | — | 0.38× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $37.4M | $21.6M | ||
| Q3 25 | $32.3M | $35.9M | ||
| Q2 25 | $44.8M | $49.8M | ||
| Q1 25 | $60.2M | $37.7M | ||
| Q4 24 | $84.3M | $35.7M | ||
| Q3 24 | $37.2M | $39.4M | ||
| Q2 24 | $35.8M | $34.9M | ||
| Q1 24 | $63.5M | $33.0M |
| Q4 25 | — | $104.4M | ||
| Q3 25 | — | $104.7M | ||
| Q2 25 | — | $105.0M | ||
| Q1 25 | — | $104.6M | ||
| Q4 24 | — | $155.2M | ||
| Q3 24 | — | $155.7M | ||
| Q2 24 | — | $162.2M | ||
| Q1 24 | — | $162.6M |
| Q4 25 | $126.6M | $273.9M | ||
| Q3 25 | $64.7M | $269.9M | ||
| Q2 25 | $79.3M | $263.5M | ||
| Q1 25 | $93.5M | $258.7M | ||
| Q4 24 | $111.8M | $253.0M | ||
| Q3 24 | $128.8M | $253.2M | ||
| Q2 24 | $148.9M | $245.2M | ||
| Q1 24 | $166.1M | $233.7M |
| Q4 25 | $329.5M | $2.2B | ||
| Q3 25 | $280.7M | $2.2B | ||
| Q2 25 | $301.0M | $2.3B | ||
| Q1 25 | $323.0M | $2.3B | ||
| Q4 24 | $348.6M | $2.3B | ||
| Q3 24 | $376.7M | $2.3B | ||
| Q2 24 | $398.8M | $2.4B | ||
| Q1 24 | $413.6M | $2.3B |
| Q4 25 | — | 0.38× | ||
| Q3 25 | — | 0.39× | ||
| Q2 25 | — | 0.40× | ||
| Q1 25 | — | 0.40× | ||
| Q4 24 | — | 0.61× | ||
| Q3 24 | — | 0.61× | ||
| Q2 24 | — | 0.66× | ||
| Q1 24 | — | 0.70× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-11.7M | $34.4M |
| Free Cash FlowOCF − Capex | $-11.8M | $33.4M |
| FCF MarginFCF / Revenue | -63.6% | 140.2% |
| Capex IntensityCapex / Revenue | 0.8% | 4.0% |
| Cash ConversionOCF / Net Profit | — | 6.08× |
| TTM Free Cash FlowTrailing 4 quarters | $-18.5M | $54.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-11.7M | $34.4M | ||
| Q3 25 | $-6.5M | $14.0M | ||
| Q2 25 | $17.5M | $5.5M | ||
| Q1 25 | $-13.5M | $2.2M | ||
| Q4 24 | $-16.8M | $93.2M | ||
| Q3 24 | $-10.4M | $11.9M | ||
| Q2 24 | $-14.8M | $54.9M | ||
| Q1 24 | $-28.6M | $-11.9M |
| Q4 25 | $-11.8M | $33.4M | ||
| Q3 25 | $-7.9M | $13.7M | ||
| Q2 25 | $17.4M | $5.2M | ||
| Q1 25 | $-16.0M | $2.1M | ||
| Q4 24 | $-25.5M | $89.4M | ||
| Q3 24 | $-19.4M | $10.5M | ||
| Q2 24 | $-21.3M | $53.8M | ||
| Q1 24 | $-30.3M | $-12.8M |
| Q4 25 | -63.6% | 140.2% | ||
| Q3 25 | -52.5% | 57.4% | ||
| Q2 25 | 94.7% | 23.0% | ||
| Q1 25 | -107.4% | 10.0% | ||
| Q4 24 | -150.6% | 394.0% | ||
| Q3 24 | -132.5% | 49.0% | ||
| Q2 24 | -118.6% | 278.6% | ||
| Q1 24 | -177.5% | -71.8% |
| Q4 25 | 0.8% | 4.0% | ||
| Q3 25 | 9.6% | 1.3% | ||
| Q2 25 | 0.8% | 1.0% | ||
| Q1 25 | 17.0% | 0.3% | ||
| Q4 24 | 51.6% | 16.7% | ||
| Q3 24 | 61.3% | 6.7% | ||
| Q2 24 | 36.4% | 5.9% | ||
| Q1 24 | 9.8% | 4.8% |
| Q4 25 | — | 6.08× | ||
| Q3 25 | — | 2.02× | ||
| Q2 25 | — | 0.92× | ||
| Q1 25 | — | 0.48× | ||
| Q4 24 | — | 15.23× | ||
| Q3 24 | — | 2.63× | ||
| Q2 24 | — | 59.35× | ||
| Q1 24 | — | -6.24× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
